2025. Glucose-Responsive Nanoparticles for Targeted Insulin Delivery in the Treatment of Diabetes. Journal of Carcinogenesis. 24, 4s (Sep. 2025), 914–927. DOI:https://doi.org/10.64149/J.Carcinog.24.4s.914-927.